These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32403389)

  • 1. Use of Glycated Hemoglobin (A1c) as a Biomarker for Vascular Risk in Type 2 Diabetes: Its Relationship with Matrix Metalloproteinases-2, -9 and the Metabolism of Collagen IV and Elastin.
    Kostov K; Blazhev A
    Medicina (Kaunas); 2020 May; 56(5):. PubMed ID: 32403389
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between Lipid Indices, Type IV Collagen Turnover and the Development of Microvascular Complications in Diabetic Patients with Arterial Hypertension.
    Nikolov A; Tzekova M; Blazhev A
    Folia Med (Plovdiv); 2019 Jun; 61(2):231-239. PubMed ID: 31301656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Anti-Collagen IV IgM and IgG Antibodies as Indicators of Low Vascular Turnover of Collagen IV in Patients with Long-Term Complications of Type 2 Diabetes.
    Kostov K; Blazhev A
    Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34069322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of determining the levels of serum collagen type IV in diagnosing early diabetic nephropathy.
    Xu X; Wu Z; Zhou Q; Zhang Y; Wu D
    Ren Fail; 2002 Nov; 24(6):747-53. PubMed ID: 12472197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Concentrations of Endothelin-1 and Matrix Metalloproteinases-2, -9 in Pre-Hypertensive and Hypertensive Patients with Type 2 Diabetes.
    Kostov K; Blazhev A; Atanasova M; Dimitrova A
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of free antielastin antibodies among diabetic children.
    Nicoloff G; Blazhev A; Petrova C; Christova P; Jordanova-Laleva P; Dekov D; Dorovski P
    J Investig Med; 2005 Apr; 53(3):128-34. PubMed ID: 15921032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy.
    Tashiro K; Koyanagi I; Ohara I; Ito T; Saitoh A; Horikoshi S; Tomino Y
    J Clin Lab Anal; 2004; 18(3):206-10. PubMed ID: 15103687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal levels of serum antielastin antibodies in children with diabetes mellitus type 1.
    Nicoloff G; Weiss AS; Iotova V; Tzaneva V; Petrova C; Domuschieva N; Nikolov A; Tzvetanov P; Christova P
    J Investig Med; 2006 Dec; 54(8):461-7. PubMed ID: 17169270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antibodies to collagen type IV and development of diabetic vascular complications in children with type 1 (insulin-dependent) diabetes mellitus. A longitudinal study.
    Nicoloff G; Baydanoff S; Petrova Ch; Christova P
    Vascul Pharmacol; 2002 Mar; 38(3):143-7. PubMed ID: 12402512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c.
    Zagami RM; Di Pino A; Urbano F; Piro S; Purrello F; Rabuazzo AM
    Atherosclerosis; 2015 Dec; 243(2):395-401. PubMed ID: 26520892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum type IV collagen concentrations in diabetic patients with microangiopathy as determined by enzyme immunoassay with monoclonal antibodies.
    Matsumoto E; Matsumoto G; Ooshima A; Kikuoka H; Bessho H; Miyamura K; Nanjo K
    Diabetes; 1990 Aug; 39(8):885-90. PubMed ID: 1695588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy.
    van Ark J; Hammes HP; van Dijk MC; Lexis CP; van der Horst IC; Zeebregts CJ; Vervloet MG; Wolffenbuttel BH; van Goor H; Hillebrands JL
    Cardiovasc Diabetol; 2013 Aug; 12():116. PubMed ID: 23945089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control and the risk of multiple microvascular diabetic complications.
    Schellhase KG; Koepsell TD; Weiss NS
    Fam Med; 2005 Feb; 37(2):125-30. PubMed ID: 15690253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease.
    Signorelli SS; Malaponte G; Libra M; Di Pino L; Celotta G; Bevelacqua V; Petrina M; Nicotra GS; Indelicato M; Navolanic PM; Pennisi G; Mazzarino MC
    Vasc Med; 2005 Feb; 10(1):1-6. PubMed ID: 15920993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes.
    Maxwell PR; Timms PM; Chandran S; Gordon D
    Diabet Med; 2001 Oct; 18(10):777-80. PubMed ID: 11678966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association of anti-elastin IgA antibodies with development of retinopathy in diabetic children.
    Nicoloff G; Baydanoff S; Stanimirova N; Petrova C; Christova P
    Gen Pharmacol; 2000 Aug; 35(2):83-7. PubMed ID: 11707314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing type 2 diabetes using Hemoglobin A1c: a systematic review and meta-analysis of the diagnostic cutpoint based on microvascular complications.
    Butler AE; English E; Kilpatrick ES; Östlundh L; Chemaitelly HS; Abu-Raddad LJ; Alberti KGMM; Atkin SL; John WG
    Acta Diabetol; 2021 Mar; 58(3):279-300. PubMed ID: 33141338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.
    Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Piccinni MN; Peros E; Geroldi D; Fogari E; D'Angelo A
    Endothelium; 2007; 14(1):45-51. PubMed ID: 17364896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-collagen type IV IgM antibodies and development of diabetic nephropathy in diabetics with essential hypertension.
    Nikolov A; Tsinlikov I; Tsinlikova I; Nicoloff G; Blazhev A; Garev A
    Cent Eur J Immunol; 2016; 41(1):86-92. PubMed ID: 27095927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of non-surgical periodontal therapy on C-reactive protein, oxidative stress, and matrix metalloproteinase (MMP)-9 and MMP-2 levels in patients with type 2 diabetes: a randomized controlled study.
    Koromantzos PA; Makrilakis K; Dereka X; Offenbacher S; Katsilambros N; Vrotsos IA; Madianos PN
    J Periodontol; 2012 Jan; 83(1):3-10. PubMed ID: 21627458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.